Logo image of PHLT

PERFORMANT HEALTHCARE INC (PHLT) Stock Fundamental Analysis

USA - NASDAQ:PHLT - US71377E1055 - Common Stock

7.72 USD
+0.01 (+0.13%)
Last: 10/8/2025, 8:08:24 PM
7.73 USD
+0.01 (+0.13%)
After Hours: 10/8/2025, 8:08:24 PM
Fundamental Rating

3

Taking everything into account, PHLT scores 3 out of 10 in our fundamental rating. PHLT was compared to 101 industry peers in the Health Care Providers & Services industry. PHLT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. PHLT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PHLT had negative earnings in the past year.
In the past year PHLT had a positive cash flow from operations.
In the past 5 years PHLT always reported negative net income.
Of the past 5 years PHLT 4 years had a positive operating cash flow.
PHLT Yearly Net Income VS EBIT VS OCF VS FCFPHLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

PHLT has a Return On Assets of -0.80%. This is comparable to the rest of the industry: PHLT outperforms 43.56% of its industry peers.
PHLT's Return On Equity of -1.08% is in line compared to the rest of the industry. PHLT outperforms 51.49% of its industry peers.
The Return On Invested Capital of PHLT (0.19%) is worse than 61.39% of its industry peers.
Industry RankSector Rank
ROA -0.8%
ROE -1.08%
ROIC 0.19%
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
PHLT Yearly ROA, ROE, ROICPHLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

Looking at the Operating Margin, with a value of 0.16%, PHLT is doing worse than 61.39% of the companies in the same industry.
The Profit Margin and Gross Margin are not available for PHLT so they could not be analyzed.
Industry RankSector Rank
OM 0.16%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHLT Yearly Profit, Operating, Gross MarginsPHLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

More info and screens

6

2. Health

2.1 Basic Checks

PHLT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PHLT has more shares outstanding
Compared to 5 years ago, PHLT has more shares outstanding
The debt/assets ratio for PHLT is higher compared to a year ago.
PHLT Yearly Shares OutstandingPHLT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PHLT Yearly Total Debt VS Total AssetsPHLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 13.38 indicates that PHLT is not in any danger for bankruptcy at the moment.
PHLT has a Altman-Z score of 13.38. This is amongst the best in the industry. PHLT outperforms 95.05% of its industry peers.
PHLT has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PHLT (0.10) is better than 77.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 13.38
ROIC/WACC0.02
WACC9.09%
PHLT Yearly LT Debt VS Equity VS FCFPHLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.64 indicates that PHLT has no problem at all paying its short term obligations.
The Current ratio of PHLT (2.64) is better than 81.19% of its industry peers.
A Quick Ratio of 2.64 indicates that PHLT has no problem at all paying its short term obligations.
The Quick ratio of PHLT (2.64) is better than 81.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.64
Quick Ratio 2.64
PHLT Yearly Current Assets VS Current LiabilitesPHLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.50% over the past year.
Looking at the last year, PHLT shows a quite strong growth in Revenue. The Revenue has grown by 15.21% in the last year.
The Revenue has been decreasing by -3.95% on average over the past years.
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%

3.2 Future

PHLT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 50.55% yearly.
Based on estimates for the next years, PHLT will show a quite strong growth in Revenue. The Revenue will grow by 11.37% on average per year.
EPS Next Y89.54%
EPS Next 2Y60.48%
EPS Next 3Y50.55%
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHLT Yearly Revenue VS EstimatesPHLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
PHLT Yearly EPS VS EstimatesPHLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

PHLT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 103.21, PHLT can be considered very expensive at the moment.
PHLT's Price/Forward Earnings is on the same level as the industry average.
PHLT is valuated expensively when we compare the Price/Forward Earnings ratio to 23.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 103.21
PHLT Price Earnings VS Forward Price EarningsPHLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PHLT is valued a bit more expensive than the industry average as 62.38% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 94.8
PHLT Per share dataPHLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PHLT's earnings are expected to grow with 50.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.48%
EPS Next 3Y50.55%

More info and screens

0

5. Dividend

5.1 Amount

PHLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERFORMANT HEALTHCARE INC

NASDAQ:PHLT (10/8/2025, 8:08:24 PM)

After market: 7.73 +0.01 (+0.13%)

7.72

+0.01 (+0.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners88.43%
Inst Owner ChangeN/A
Ins Owners5.34%
Ins Owner Change4.72%
Market Cap609.88M
Analysts48.89
Price Target7.91 (2.46%)
Short Float %13.74%
Short Ratio6.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)188.22%
Min EPS beat(2)100%
Max EPS beat(2)276.44%
EPS beat(4)4
Avg EPS beat(4)104.9%
Min EPS beat(4)1.96%
Max EPS beat(4)276.44%
EPS beat(8)8
Avg EPS beat(8)102.34%
EPS beat(12)11
Avg EPS beat(12)79.64%
EPS beat(16)14
Avg EPS beat(16)64.19%
Revenue beat(2)2
Avg Revenue beat(2)10.95%
Min Revenue beat(2)9%
Max Revenue beat(2)12.91%
Revenue beat(4)2
Avg Revenue beat(4)4.88%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)12.91%
Revenue beat(8)6
Avg Revenue beat(8)3.99%
Revenue beat(12)7
Avg Revenue beat(12)1.42%
Revenue beat(16)10
Avg Revenue beat(16)2.44%
PT rev (1m)0%
PT rev (3m)10.71%
EPS NQ rev (1m)-33.3%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-188.87%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 103.21
P/S 4.44
P/FCF N/A
P/OCF 126.9
P/B 7.42
P/tB 17.49
EV/EBITDA 94.8
EPS(TTM)-0.01
EYN/A
EPS(NY)0.07
Fwd EY0.97%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.06
OCFY0.79%
SpS1.74
BVpS1.04
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.8%
ROE -1.08%
ROCE 0.24%
ROIC 0.19%
ROICexc 0.21%
ROICexgc 0.48%
OM 0.16%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.6%
ROA(5y)-8.46%
ROE(3y)-9.98%
ROE(5y)-15.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 1.25
Cap/Depr 84.63%
Cap/Sales 3.82%
Interest Coverage 0.27
Cash Conversion 74.84%
Profit Quality N/A
Current Ratio 2.64
Quick Ratio 2.64
Altman-Z 13.38
F-Score6
WACC9.09%
ROIC/WACC0.02
Cap/Depr(3y)88.51%
Cap/Depr(5y)80.81%
Cap/Sales(3y)4.21%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%175%
EPS Next Y89.54%
EPS Next 2Y60.48%
EPS Next 3Y50.55%
EPS Next 5YN/A
Revenue 1Y (TTM)15.21%
Revenue growth 3Y-0.38%
Revenue growth 5Y-3.95%
Sales Q2Q%28.75%
Revenue Next Year10.75%
Revenue Next 2Y10.42%
Revenue Next 3Y11.37%
Revenue Next 5YN/A
EBIT growth 1Y104.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year212.29%
EBIT Next 3Y72.41%
EBIT Next 5YN/A
FCF growth 1Y-183.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.31%
OCF growth 3Y88.66%
OCF growth 5YN/A